Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Lei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7067-3732; OpenAlex author ID A5115695525. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper

Papers 3

  1. Exploring the value of multiparametric quantitative MRI in the assessment of pancreatic ductal adenocarcinoma fibrosis grading. Co-author DOI 10.1007/s00330-024-11246-w↗
  2. MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic cancer. Last author DOI 10.1038/s41598-024-52729-6↗
  3. RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial-mesenchymal transition. Co-author DOI 10.1186/s40170-024-00362-2↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianwei Xu · 1 shared paper, 2025 · strength 0.28
  2. Dexin Yu · 1 shared paper, 2025 · strength 0.28
  3. Fangqing Wang · 1 shared paper, 2025 · strength 0.28
  4. Zhicheng Liu · 1 shared paper, 2024 · strength 0.24
  5. Jie Gao · 1 shared paper, 2024 · strength 0.24
  6. Jianwei Xu · 1 shared paper, 2024 · strength 0.23
  7. Han Liu · 1 shared paper, 2024 · strength 0.23
  8. Feng Li · 1 shared paper, 2024 · strength 0.23
  9. Rui Zhao · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.